Tamoxifen Oral Product

DRUG2 trials

Sponsors

Sun Yat-sen University, Seoul National University Hospital

Conditions

Breast Cancer MetastaticHormone Receptor-positive Breast CancerPremenopausal Breast Cancer

Phase 2

Efficacy of High Dose Tamoxifen to Advanced Hormone Receptor-High Expressed Breast Cancer

CompletedNCT03045653

Sun Yat-sen UniversityBreast Cancer Metastatic

Start: 2017-09-01End: 2019-02-21Updated: 2022-03-28

Higher Dose Preoperative taMOxifen in Premenopausal bREast Cancer Patients

Active, not recruitingNCT04997941

Seoul National University HospitalHormone Receptor-positive Breast Cancer, Premenopausal Breast Cancer

Start: 2021-10-21End: 2028-12-31Target: 238Updated: 2024-04-23